Get Support

Learn Mode

ELV - Elevance Health Inc

197

$292.75

$7.96 (2.795%)

At market close

$292.36

-$0.39 (-0.132%)

After Hours 3/31/26, 9:39 PM

3.57/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

ELV

Valuation Score

View as %

Stock Unlock

1D

1W

1M

YTD

1Y

3Y

5Y

Max

Stock Profile

Market Cap

$64.77B

Industry

Health Care

EPS (TTM)

$25.55

P/E (TTM)

11.44

Div & Yield

$6.88 (2.35%)

FCF Payout Ratio

47.96%

P/S (TTM)

0.33

P/B

1.48

Diluted Shares

221.60M

Ex-Dividend

2026-03-10

Next Earnings

04-22

Forward P/E

11.19

Payout Ratio

26.89%

P/FCF (TTM)

20.41

FCF Yield

4.90%

Earnings Yield

8.74%

52 Week Range

Score Card

Explore Scores Tab

3.57

Good

Elevance Health Inc has grown revenue at 12.62% over the past year, which is strong growth. Also, it has seen its diluted average shares outstanding decrease by -3.99% over the past year, which suggests the company is buying back shares.

Valuation Model

Key Score

1.00

Very Bad

Management

3.00

Average

Growth

5.00

Very Good

Profitability

5.00

Very Good

Fin. Health

1.00

Very Bad

Dividends

1.00

Very Bad

Analyst

4.00

Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

3 new filings were in the last 7 days

Filter Form Types

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-03-27 16:21:47

Form DEF 14A

Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-03-27 16:21:11

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-26 18:03:38

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:10:37

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-10 06:02:21

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-09 16:45:08

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-06 16:17:51

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-06 08:03:27

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 17:00:06

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:59:45

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:59:14

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-04 16:58:49

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-03-25

High:

$516.02

76.3%

Avg:

$392.72

34.1%

Low:

$335.32

14.5%

(% change is relative to the current stock price: $292.75)

Analyst Recommendations

Go to Analyst Tab

3.71

Good

18%

Strong Buy (5)

36%

Buy (10)

46%

Hold (13)

0%

Sell (0)

0%

Strong Sell (0)

About

Website
https://www.elevancehealth.com/
Address
220 Virginia Avenue, Indianapolis INDIANA, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1156039

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 96,129 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

IPO Date

2001-10-30

Industry

Health Care

Total Employees

96,129

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Health Care Providers & Services

GICS Sub

Managed Health Care

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services